Pharmaceutical Medicine and Drug Development Programs
For Australia to play its full role in the development of new drugs, particularly in the early phase of drug development, and to maintain high standards of delivery of drugs to the market, it is essential that Australian Pharmaceutical Companies have staff adequately trained and skilled to perform in these areas. Training in these skills must meet assessable standards which are compatible with international scientific, clinical, legal and regulatory conventions. This is important for Australia to compete in local and international drug development activities and for the career development of those involved.
Those working in Research & Development, Medical, Medical Information and Regulatory Departments in Pharmaceutical Companies are responsible for the discovery and selection of new drugs for development, their evaluation for efficacy and safety in preclinical and clinical studies, pharmacovigilance (e.g. monitoring and reporting of adverse drug reactions), registration of new drugs and associated regulatory activities, pharmacoeconomic studies, and other activities.
The UNSW programs in Drug Development and Pharmaceutical Medicine have been designed to ensure staff are adequately equipped with the skills needed to competently perform their roles in the industry.
The programs also provide an excellent opportunity for recent graduates in Medical Sciences, and those in a variety of research positions to upgrade skills.
The Prospectus provides detailed information on the Programs in the Development of New Medicines offered.